06/11/2025
We’re delighted to have helped our wonderful client BioPharma Credit PLC with its latest annual report.
BioPharma Credit provides investors with an opportunity to gain exposure to the fast-growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. Its primary objective is to generate predictable income for shareholders over the long term.
B&C’s design for the annual report emphasises the company’s market-leading position, established track record, size and consistent performance. The use of clean typography, white space, considered use of colours and striking imagery all help convey the company's professionalism and reinforce its emphasis on sustainable investing and its credibility in the life sciences debt space. The layout presents clear sectioning for easy navigation, helping to guide the reader from an initial overview of its strategy through its market and portfolio review, investment managers' report, asset performance, its approach to stakeholder engagement, risk, ESG and governance, and finally onto its detailed financial statements.
We’d like to thank our wonderful clients at the company and its investment manager, Pharmakon Advisors.
If you’d like to find out how we can help your corporate reporting work harder, chat with us today: hello@blackandcallow.com
